New platinum antitumor complexes
Open Access
- 1 December 1993
- journal article
- review article
- Published by Elsevier
- Vol. 15 (3) , 191-219
- https://doi.org/10.1016/1040-8428(93)90042-3
Abstract
No abstract availableThis publication has 142 references indexed in Scilit:
- Characterization of high mobility group protein binding to cisplatin-damaged DNABiochemical and Biophysical Research Communications, 1992
- Second-line treatment of advanced measurable ovarian cancer with iproplatin: A Southwest oncology group studyEuropean Journal of Cancer and Clinical Oncology, 1991
- 2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumorsJournal of Medicinal Chemistry, 1991
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Resistance to platinum compounds: Mechanisms and beyondEuropean Journal of Cancer and Clinical Oncology, 1989
- Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1989
- Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cellsEuropean Journal of Cancer and Clinical Oncology, 1989
- Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell lineEuropean Journal of Cancer and Clinical Oncology, 1989
- Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationBiochemistry, 1985
- Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteusMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1978